ECSP22047989A - Formulaciones que comprenden un mineral y/o una vitamina y un polisac?rido, composiciones de las mismas y uso de las mismas en la suplementaci?n de dicho mineral y/o vitamina - Google Patents

Formulaciones que comprenden un mineral y/o una vitamina y un polisac?rido, composiciones de las mismas y uso de las mismas en la suplementaci?n de dicho mineral y/o vitamina

Info

Publication number
ECSP22047989A
ECSP22047989A ECSENADI202247989A ECDI202247989A ECSP22047989A EC SP22047989 A ECSP22047989 A EC SP22047989A EC SENADI202247989 A ECSENADI202247989 A EC SENADI202247989A EC DI202247989 A ECDI202247989 A EC DI202247989A EC SP22047989 A ECSP22047989 A EC SP22047989A
Authority
EC
Ecuador
Prior art keywords
vitamin
mineral
formulations
compositions
supplementation
Prior art date
Application number
ECSENADI202247989A
Other languages
English (en)
Inventor
Andrea Lacorte
Germano Tarantino
Elisa Brilli
Original Assignee
Alesco Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alesco Srl filed Critical Alesco Srl
Publication of ECSP22047989A publication Critical patent/ECSP22047989A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Dispersion Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invenci?n se refiere a una formulaci?n en forma s?lida a base de un nutriente que comprende: (a) un mineral o una vitamina (b) un fosfol?pido, (c) un primer agente seleccionado de (c-i) carragenina y (c-ii) goma de acacia, y, opcionalmente, (d) un ?ster de sacarosa y/o (e) un almid?n de origen vegetal. Adem?s, la presente invenci?n se relaciona con una composici?n que comprende al menos una de dichas formulaciones y el uso de la misma en el tratamiento de una deficiencia de dicho mineral y/o vitamina. Por ?ltimo, la presente invenci?n se refiere a un proceso para la preparaci?n de dichas formulaciones o composiciones.
ECSENADI202247989A 2019-12-04 2022-06-15 Formulaciones que comprenden un mineral y/o una vitamina y un polisac?rido, composiciones de las mismas y uso de las mismas en la suplementaci?n de dicho mineral y/o vitamina ECSP22047989A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102019000023016A IT201900023016A1 (it) 2019-12-04 2019-12-04 Formulazioni comprendenti un minerale e un polisaccaride, loro composizioni e loro uso nella supplementazione di detto minerale

Publications (1)

Publication Number Publication Date
ECSP22047989A true ECSP22047989A (es) 2022-08-31

Family

ID=70154909

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSENADI202247989A ECSP22047989A (es) 2019-12-04 2022-06-15 Formulaciones que comprenden un mineral y/o una vitamina y un polisac?rido, composiciones de las mismas y uso de las mismas en la suplementaci?n de dicho mineral y/o vitamina

Country Status (16)

Country Link
US (1) US20230019690A1 (es)
EP (1) EP4069194A1 (es)
JP (1) JP7881468B2 (es)
KR (1) KR20220122654A (es)
CN (1) CN115052582A (es)
BR (1) BR112022010834A2 (es)
CA (1) CA3163312A1 (es)
EC (1) ECSP22047989A (es)
GE (1) GEP20257836B (es)
IL (1) IL293452A (es)
IT (1) IT201900023016A1 (es)
JO (1) JOP20220136A1 (es)
MX (1) MX2022006828A (es)
SA (1) SA522432861B1 (es)
UA (1) UA129875C2 (es)
WO (1) WO2021111404A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT202200010583A1 (it) * 2022-05-23 2023-11-23 Neilos S R L “Composizione nutraceutica o farmaceutica per l’infertilità maschile”
WO2025056416A1 (en) * 2023-09-11 2025-03-20 Dsm Ip Assets B.V. Lipid matrix-based particles
WO2026083282A2 (en) 2024-10-15 2026-04-23 Pharmanutra S.P.A. Formulations comprising at least one vitamin and at least one phosphate salt, their compositions, and their use in supplementing said at least one vitamin

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3680346D1 (de) * 1985-01-29 1991-08-29 Abbott Lab Enterales hypoallergenisches ernaehrungsrezept.
CN1077342A (zh) * 1992-04-17 1993-10-20 金昌松 米、面类强化营养粉的配制方法
US6541048B2 (en) * 1999-09-02 2003-04-01 Wm. Wrigley Jr. Company Coated chewing gum products containing an acid blocker and process of preparing
US7744930B2 (en) * 2002-11-22 2010-06-29 Shaklee Corporation Compositions, methods and kits for enhancing weight loss while inhibiting loss of lean body mass
US7829126B2 (en) 2005-10-26 2010-11-09 Abbott Laboratories Infant formulas containing docosahexaenoic acid and lutein
ATE535283T1 (de) 2006-02-17 2011-12-15 Viridis Pharmaceutical Ltd Beschleunigungsmittel für die calciumabsorption
JP5256041B2 (ja) 2006-10-31 2013-08-07 株式会社カネカ 生理活性物質含有粒子状組成物およびその製造方法
JP2008174537A (ja) 2006-12-20 2008-07-31 Fujifilm Corp 粉末組成物並びに、これを含む食品組成物、化粧品組成物及び医薬品組成物
CN101455401B (zh) * 2009-01-16 2012-01-18 北京天维新探生物科技有限公司 复合型多功能食品营养强化剂
JP5733930B2 (ja) 2009-09-09 2015-06-10 武田薬品工業株式会社 固形製剤
WO2012020279A1 (en) 2010-08-13 2012-02-16 Compagnie Gervais Danone Product for the upper gastric sphere
CN102077944B (zh) * 2010-09-20 2013-08-21 王强 一种前列腺患者专用的海洋特膳食品
ITMI20121350A1 (it) 2012-07-31 2014-02-01 Alesco Srl Composizione solido a base di ferro per uso nelle condizioni di deficienza di ferro.
KR101771774B1 (ko) 2014-03-21 2017-08-28 주식회사 엘지화학 점착 필름용 광경화성 수지 조성물 및 점착 필름
US20160346303A1 (en) 2014-10-29 2016-12-01 Glycom A/S Synthetic composition and method for treating irritable bowel syndrome
US20160278415A1 (en) * 2015-01-30 2016-09-29 Nutrient Foods, Llc Food Compositions Containing All Essential Nutrients
CN111093667B (zh) 2017-07-11 2025-10-21 合利他命制药株式会社 配合维生素b1类的固体制剂
IT201800006288A1 (it) * 2018-06-13 2019-12-13 Composizioni comprendenti minerali sucrosomiali contenenti sali minerali per uso nelle condizioni di deficienza di tali minerali

Also Published As

Publication number Publication date
MX2022006828A (es) 2022-09-23
KR20220122654A (ko) 2022-09-02
JP7881468B2 (ja) 2026-06-29
GEP20257836B (en) 2025-12-10
US20230019690A1 (en) 2023-01-19
EP4069194A1 (en) 2022-10-12
AU2020396464A1 (en) 2022-06-16
GEAP202515978A (en) 2025-08-11
SA522432861B1 (ar) 2024-08-29
UA129875C2 (uk) 2025-08-27
WO2021111404A1 (en) 2021-06-10
JOP20220136A1 (ar) 2022-06-02
IL293452A (en) 2022-07-01
JP2023505246A (ja) 2023-02-08
BR112022010834A2 (pt) 2022-08-23
IT201900023016A1 (it) 2021-06-04
CN115052582A (zh) 2022-09-13
CA3163312A1 (en) 2021-06-10

Similar Documents

Publication Publication Date Title
CL2020000632A1 (es) Composición y método para el tratamiento del autismo.
UY37952A (es) Formulaciones de un inhibidor de la quinasa trk macrocíclica
BR112012012862A2 (pt) composição farmacêutica compreendendo oligopeptídeos
BR112019024641A2 (pt) Composições de óleo contendo éster alquílico intensificado e métodos de fabricação e utilização das mesmas
MX2017003456A (es) Composiciones no grasas para el cuidado personal.
MEP18208A (en) Immune response modifier foam formulations
BR112014031284A2 (pt) composição, método de formar uma composição, e, modificador de reologia
BR112012006692A2 (pt) composição farmacêutica compreendendo ácido graxo de omega-3 e um derivado de hidróxi de uma estatina e métodos de uso das mesmas
MX378687B (es) Formulacion de vitamina soluble en grasa.
AR067084A1 (es) Dispersion solida que contiene revaprazan y procedimiento para la preparacion de la misma. composicion farmaceutica.
CL2019000607A1 (es) Composición para aplicación tópica con actividad antifúngica.
WO2015061798A3 (en) Compositions and methods comprising yeast organisms and lipid extracts thereof
JOP20220136A1 (ar) صياغات تشتمل على معدن و/أو فيتامين وبولي سكاريد، تركيبات منها واستخدامها في المعدن و/أو الفيتامين المُكمل المذكور
MX2021015311A (es) Formulas parenterales de lisofosfatidilcolina tales como lpc-dha, lpc-epa y sus usos en terapia.
PE20160866A1 (es) Extracto vegetal con esteres de sacarosa como principio activo para su uso en composiciones cosmeticas, dermatologicas o nutricosmeticas
CL2020002519A1 (es) Composiciones de erenumab y usos de las mismas
MX2022003398A (es) Composicion micelar inmunoestimulante.
BR112014003264A8 (pt) composições nutricionais compreendendo uma fibra viscosa solúvel e um extrato de planta contendo polifenol
BR112016028561A8 (pt) composição e forma de dosagem compreendendo um óleo marinho que compreende ácidos graxos, e, uso das mesmas
SE0201566D0 (sv) New composition
MX389461B (es) Composiciones que comprenden una matriz de polisacarido para la liberacion controlada de ingredientes activos
BRPI0416747A (pt) métodos e formulações para o tratamento de condições médicas relacionadas à dihidrotesterona elevada
AR107195A1 (es) Composición lípida vegetal para promover el crecimiento del cabello, método para promover el crecimiento del cabello y uso de dichos lípidos vegetales
SG10201807034XA (en) A pharmaceutical composition for improving or preventing progression of Chronic Kidney Disease
DE602006011127D1 (de) Fettsäure-benzenediol-derivate sowie herstellungs- und verwendungsverfahren dafür